top of page
© Hairuhusiwi kukopi bila kibali cha ULYCLINIC

Mwandishi:

Mhariri:

Imeboreshwa:

ULY CLINIC

ULY CLINIC

20 Oktoba 2026, 08:11:38

Image-empty-state.png

Fluid overload in chronic kidney disease

Investigations

  • BNP/NT-proBNP; creatinine, BUN, eGFR; serum and urine sodium, potassium, chloride; serum osmolality; haemoglobin/haematocrit; albumin and total protein.

Non-pharmacological management

  • Salt below 90 mmol/day (about 5–6 g, one teaspoon); education on fluid and salt restriction and daily weight; avoid NSAIDs and fluid-retaining drugs; adjust doses to kidney function.

Pharmacological management

  • First line: A: furosemide (PO) 20–40 mg once or twice daily, titrated up to 200 mg/day, OR S: torsemide (PO) 10–20 mg once daily, up to 200 mg/day.

  • Add if diuresis is inadequate: D: hydrochlorothiazide 25–50 mg every 12 hours, OR S: metolazone 2.5–5 mg once daily 30 minutes before the loop diuretic (watch for low potassium and sodium).

  • Monitor BP, electrolytes, kidney function and volume status.

Refractory fluid overload

  • A: Furosemide IV 20–40 mg every 6–8 hours (up to 600–1500 mg/day in severe cases); maximum single bolus 160–200 mg; doses above 80 mg as slow infusion at no more than 4 mg/minute.

  • OR S: torsemide IV 10–20 mg daily, titrated to 100–200 mg/day.

  • With hypoalbuminaemia: S: albumin 20% or 25% 0.5–1 g/kg IV (maximum 2 g/kg/day; children over 30 minutes–2 hours), repeated every 24–48 hours, given with furosemide 1–2 mg/kg IV; avoid in uncontrolled hypertension, heart failure or pulmonary oedema.

  • Refer to a nephrologist if refractory, or with resistant hypertension, rapid decline, severe albuminuria, electrolyte disturbance, AKI on CKD or need for dialysis; refer early once eGFR is below 30.

Imeandikwa:

20 Oktoba 2026, 08:09:44

Rejea za mada hii:

  1. Ministry of Health, United Republic of Tanzania. Standard Treatment Guidelines and National Essential Medicines List for Tanzania Mainland (STG & NEMLIT). 7th ed. Dodoma: Ministry of Health; 2026. Chapter 21, Kidney and Urological Disorders: sections 21.1.3 Fluid overload and 21.1.3.1 Refractory Fluid Overload, pp. 527–528.

bottom of page